Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
David Barzilai, MD, PhD, MBA, MS, DipABLM
Contributor
Dr. David Barzilai is a longevity medicine physician and Harvard Medical School lecturer focused on advancing healthy longevity through evidence-based and precision medicine. He served as medical editor of Harvard Health Publishing's Pathways to Longevity, its first Special Health Report dedicated to the field. A diplomate of the American Board of Lifestyle Medicine, he holds a PhD in health services research and serves as inaugural faculty member and trustee at the Geneva College of Longevity Science. He is known for making complex scientific advances accessible and actionable for clinicians, executives, and policymakers.
Posts by David Barzilai, MD, PhD, MBA, MS, DipABLM
Fatty liver disease: Should you be tested?
Weight-loss drug may lower risk of heart attacks and infections
Testosterone therapy without evidence of deficiency may boost heart risk
Even a little exercise linked with lower stroke risk in people with afib
Antihistamines may not offer meaningful relief from eczema symptoms
What to eat on the DASH diet
Tricep workouts you can do at home
FDA approves first mRNA-based flu vaccine
Migraine: How it's diagnosed and what that means
Mindfulness practices to reduce stress and improve focus
